Lucintel forecasts the Imatinib Drug Market in United States is expected to grow with a CAGR of 2.8% from 2025 to 2031

According to a market report by Lucintel, the future of the imatinib drug market in United States looks promising with opportunities in the philadelphia positive chronic myeloid leukemia, hyper-eosinophilic syndrome (HES), myelodysplastic syndrome (MDS), myeloproliferative diseases (MPD), and gastrointestinal stromal tumors (GIST) markets. The imat

read more

Lucintel forecasts the Imatinib Drug Market in Japan is expected to grow with a CAGR of 2.8% from 2025 to 2031

According to a market report by Lucintel, the future of the imatinib drug market in Japan looks promising with opportunities in the philadelphia positive chronic myeloid leukemia, hyper-eosinophilic syndrome (HES), myelodysplastic syndrome (MDS), myeloproliferative diseases (MPD), and gastrointestinal stromal tumors (GIST) markets. The imatinib dru

read more